Company page
Inmune Bio Inc.
Inmune Bio Inc. is a public company traded under the ticker INMB in the American market. The company has a market capitalization of approximately $43.1 million. Inmune Bio focuses on developing innovative therapies to treat diseases by harnessing the body's immune system.
- Ticker
- INMB:NASDAQ
- Asset type
- Stock
- Market cap
- $43.1M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD